Götz Ulrich Grigoleit

1.1k total citations
47 papers, 760 citations indexed

About

Götz Ulrich Grigoleit is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Götz Ulrich Grigoleit has authored 47 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 20 papers in Epidemiology and 18 papers in Oncology. Recurrent topics in Götz Ulrich Grigoleit's work include Cytomegalovirus and herpesvirus research (19 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (11 papers). Götz Ulrich Grigoleit is often cited by papers focused on Cytomegalovirus and herpesvirus research (19 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (11 papers). Götz Ulrich Grigoleit collaborates with scholars based in Germany, United States and Italy. Götz Ulrich Grigoleit's co-authors include Markus Kapp, Hermann Einsele, Hermann Einsele, Andreas K. Buck, Sabrina Kraus, Constantin Lapa, Samuel Samnick, Andreas Schirbel, Stephan Mielke and Heribert Hänscheid and has published in prestigious journals such as Blood, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Götz Ulrich Grigoleit

45 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Götz Ulrich Grigoleit Germany 16 313 297 276 151 118 47 760
Marina Deschamps France 17 445 1.4× 297 1.0× 136 0.5× 217 1.4× 109 0.9× 39 968
Yuya Nagai Japan 11 433 1.4× 226 0.8× 76 0.3× 252 1.7× 125 1.1× 43 853
Roelof A. de Paus Netherlands 16 627 2.0× 274 0.9× 201 0.7× 173 1.1× 126 1.1× 27 923
Takuya Matsumura Japan 14 219 0.7× 134 0.5× 237 0.9× 177 1.2× 50 0.4× 20 734
Isabelle Magalhaes Sweden 22 590 1.9× 410 1.4× 256 0.9× 296 2.0× 56 0.5× 52 1.2k
A Mazumder United States 12 544 1.7× 307 1.0× 165 0.6× 137 0.9× 276 2.3× 27 993
Louise Y.C. Takeshita United Kingdom 7 690 2.2× 161 0.5× 126 0.5× 305 2.0× 103 0.9× 9 1.1k
Dan Suan Australia 11 606 1.9× 211 0.7× 154 0.6× 220 1.5× 31 0.3× 26 1.0k
Vittorio Francavilla Italy 16 878 2.8× 148 0.5× 316 1.1× 157 1.0× 72 0.6× 31 1.3k
Daniele Accapezzato Italy 19 987 3.2× 204 0.7× 428 1.6× 251 1.7× 71 0.6× 47 1.6k

Countries citing papers authored by Götz Ulrich Grigoleit

Since Specialization
Citations

This map shows the geographic impact of Götz Ulrich Grigoleit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Götz Ulrich Grigoleit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Götz Ulrich Grigoleit more than expected).

Fields of papers citing papers by Götz Ulrich Grigoleit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Götz Ulrich Grigoleit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Götz Ulrich Grigoleit. The network helps show where Götz Ulrich Grigoleit may publish in the future.

Co-authorship network of co-authors of Götz Ulrich Grigoleit

This figure shows the co-authorship network connecting the top 25 collaborators of Götz Ulrich Grigoleit. A scholar is included among the top collaborators of Götz Ulrich Grigoleit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Götz Ulrich Grigoleit. Götz Ulrich Grigoleit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kluger, Harriet M., Götz Ulrich Grigoleit, Sajeve Thomas, et al.. (2025). Lifileucel tumor‐infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors. Cancer Communications. 45(10). 1229–1234. 3 indexed citations
2.
Rein, A, Florian Erhard, Lars Dölken, et al.. (2023). CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis. Frontiers in Immunology. 14. 1148841–1148841. 6 indexed citations
3.
Isberner, Nora, et al.. (2020). Determination of Letermovir Serum Levels Can Be Useful in High-Risk Clinical Settings. Journal of the Pediatric Infectious Diseases Society. 9(3). 402–403. 4 indexed citations
4.
Wiercinska, Eliza, Götz Ulrich Grigoleit, Alessandro Mazzoni, et al.. (2020). Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes. Journal of Translational Medicine. 18(1). 177–177. 28 indexed citations
5.
Isberner, Nora, et al.. (2020). Quantification of letermovir in human serum using high-performance liquid chromatography with diode array detection. Journal of Chromatography B. 1159. 122399–122399. 6 indexed citations
6.
Technau, Antje, Sascha Sauer, Ana Marcu, et al.. (2020). Prostaglandin E2 in a TLR3- and 7/8-agonist-based DC maturation cocktail generates mature, cytokine-producing, migratory DCs but impairs antigen cross-presentation to CD8+ T cells. Cancer Immunology Immunotherapy. 69(6). 1029–1042. 13 indexed citations
7.
Stemberger, Christian, Kevin M. Dennehy, Angela M. Krackhardt, et al.. (2019). Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy. PLoS ONE. 14(9). e0223258–e0223258. 3 indexed citations
8.
Zeller, Daniel, Anke Heidemeier, Götz Ulrich Grigoleit, & Wolfgang Müllges. (2017). Case report: subacute tetraplegia in an immunocompromised patient. BMC Neurology. 17(1). 31–31.
9.
Lapa, Constantin, Götz Ulrich Grigoleit, Heribert Hänscheid, et al.. (2016). Peptide Receptor Radionuclide Therapy for Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 194(11). 1428–1430. 3 indexed citations
11.
Gooden, Marloes J.M., Anna A. Rybczynska, Hans W. Nijman, et al.. (2014). Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death. Molecular Cancer. 13(1). 85–85. 21 indexed citations
12.
Fuji, Shigeo, Markus Kapp, Götz Ulrich Grigoleit, & Hermann Einsele. (2011). Adoptive immunotherapy with virus-specific T cells. Best Practice & Research Clinical Haematology. 24(3). 413–419. 22 indexed citations
13.
Müller, Nicole, Markus Kapp, Götz Ulrich Grigoleit, et al.. (2011). SMAC Mimetic BV6 Induces Cell Death in Monocytes and Maturation of Monocyte-Derived Dendritic Cells. PLoS ONE. 6(6). e21556–e21556. 44 indexed citations
15.
Schoen, Christoph, Christian Unzicker, Gernot Stuhler, et al.. (2009). Life-Threatening Infection Caused by Daptomycin-Resistant Corynebacterium jeikeium in a Neutropenic Patient. Journal of Clinical Microbiology. 47(7). 2328–2331. 25 indexed citations
16.
Grigoleit, Götz Ulrich, et al.. (2009). Indirect Effects of Cytomegalovirus Infection. European Oncology & Haematology. 3(1). 41–41. 7 indexed citations
17.
Kapp, Markus, Stefan Stevanović, Sen Mui Tan, et al.. (2009). CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT. Bone Marrow Transplantation. 43(5). 399–410. 42 indexed citations
18.
19.
Kapp, Markus, Sen Mui Tan, Hermann Einsele, & Götz Ulrich Grigoleit. (2007). Adoptive immunotherapy of HCMV infection. Cytotherapy. 9(8). 699–711. 20 indexed citations
20.
Einsele, Hermann, Markus Kapp, & Götz Ulrich Grigoleit. (2007). CMV-specific T cell therapy. Blood Cells Molecules and Diseases. 40(1). 71–75. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026